The recent controversy surrounding the Bengal Chemicals & Pharmaceuticals Ltd. (BCPL) has raised questions about its role in the production of anti-malarial drugs in India. Amid allegations that the central government has stopped providing orders to BCPL for these vital medicines, it is essential to delve into the larger context. This article expands on the critical aspects of this issue, focusing on the company’s responsibility, its contribution to the pharmaceutical sector, and its distinguished founder, Acharya Prafulla Chandra Ray.
Role of Bengal Chemicals & Pharmaceuticals Ltd.
BCPL holds the unique position of being the only Public Sector Undertaking (PSU) producing the anti-malarial drug, chloroquine phosphate, in India. PSUs are government-owned corporations where the majority share capital (51% or more) is held by either the central or state government or a combination of both. BCPL was launched on March 27, 1981, after the Indian government took over the management of Bengal Chemical and nationalised the organization on December 15, 1980.
Auditing and Quality Assurance
India’s comptroller and auditor general (CAG) oversees the auditing process for government companies, ensuring compliance with regulations and maintaining accountability. This oversight extends to BCPL as well, whose operations are monitored under the concerned authority’s watchful eyes.
The Origin of Bengal Chemicals & Pharmaceuticals Ltd.
Bengal Chemical & Pharmaceutical Works Ltd., the precursor to BCPL, was established by Acharya Prafulla Chandra Ray on April 12, 1901. This marked the birth of the first Indian company to manufacture quality Chemicals, Drugs, Pharmaceuticals, and Home Products using indigenous technology, skills, and raw materials.
The Legacy of Acharya Prafulla Chandra Ray
Known as the “Father of Indian Chemistry,” Acharya Prafulla Chandra Ray (1861-1944) was a renowned scientist and teacher. As one of the first modern Indian chemical researchers, his discovery of mercurous nitrite in 1896 remains a significant contribution to the field. The British Government honoured him with the imperial title of CIE (Companion of the Indian Empire) and later Knighthood in 1919. In 1920, he was elected General President of the Indian Science Congress.
Ray was not only a scientist but also a social reformer. He detested the caste system and other irrational social systems and was instrumental in promoting social reformation throughout his life. His successful establishment of the Bengal Chemical and Pharmaceutical Works was also a testament to his desire to encourage local enterprise and self-reliance.
The Current Controversy
Despite BCPL’s unique role and legacy, it currently faces allegations that the central government is no longer providing its orders to produce anti-malarial drugs. This claim has sparked a considerable debate about governmental responsibility and the strategic production of essential medicine in India. While the situation evolves, it’s crucial to remember BCPL’s historical significance and ongoing role in pharmaceutical production, which cannot be understated.
Last Modified: February 7, 2024